Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Iodide Peroxidase | 16 | 2013 | 34 | 2.200 |
Why?
|
Thyroid Gland | 7 | 2022 | 27 | 1.980 |
Why?
|
Thyroid Neoplasms | 2 | 2022 | 37 | 1.390 |
Why?
|
Triiodothyronine | 10 | 2015 | 28 | 1.170 |
Why?
|
Iodine Radioisotopes | 3 | 2022 | 16 | 0.900 |
Why?
|
Hyperthyroidism | 2 | 2022 | 11 | 0.880 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2022 | 13 | 0.840 |
Why?
|
Thyroxine | 7 | 2014 | 25 | 0.770 |
Why?
|
Thyroid Hormones | 5 | 2013 | 13 | 0.770 |
Why?
|
Thyroid Nodule | 2 | 2016 | 7 | 0.650 |
Why?
|
Hypothyroidism | 4 | 2015 | 31 | 0.630 |
Why?
|
Mitochondria | 2 | 2015 | 78 | 0.610 |
Why?
|
Oxygen Consumption | 4 | 2015 | 49 | 0.600 |
Why?
|
Liver | 5 | 2015 | 173 | 0.560 |
Why?
|
Thyroiditis, Suppurative | 1 | 2014 | 1 | 0.500 |
Why?
|
Coccidioidomycosis | 1 | 2014 | 7 | 0.490 |
Why?
|
Immunocompromised Host | 1 | 2014 | 45 | 0.480 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 333 | 0.470 |
Why?
|
Hormone Replacement Therapy | 2 | 2014 | 30 | 0.470 |
Why?
|
Liver Transplantation | 1 | 2014 | 79 | 0.450 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 63 | 0.410 |
Why?
|
PPAR gamma | 1 | 2008 | 12 | 0.340 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2008 | 38 | 0.340 |
Why?
|
Animals | 14 | 2014 | 4591 | 0.300 |
Why?
|
Risk Assessment | 2 | 2022 | 679 | 0.280 |
Why?
|
Mice | 9 | 2013 | 1617 | 0.280 |
Why?
|
Humans | 22 | 2022 | 29351 | 0.270 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2003 | 3 | 0.240 |
Why?
|
Endoplasmic Reticulum | 1 | 2003 | 28 | 0.240 |
Why?
|
Cell Line, Tumor | 2 | 2015 | 264 | 0.230 |
Why?
|
Homeostasis | 3 | 2015 | 82 | 0.220 |
Why?
|
Adipose Tissue, Brown | 3 | 2012 | 4 | 0.220 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2022 | 16 | 0.210 |
Why?
|
Observational Studies as Topic | 1 | 2022 | 17 | 0.210 |
Why?
|
Energy Metabolism | 3 | 2007 | 52 | 0.210 |
Why?
|
Radiometry | 1 | 2022 | 38 | 0.210 |
Why?
|
Mice, Inbred C57BL | 4 | 2012 | 444 | 0.210 |
Why?
|
Enzyme Activation | 2 | 2012 | 114 | 0.190 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 208 | 0.180 |
Why?
|
Incidence | 1 | 2022 | 752 | 0.170 |
Why?
|
Mice, Knockout | 3 | 2009 | 306 | 0.170 |
Why?
|
Insulin Resistance | 3 | 2014 | 59 | 0.170 |
Why?
|
Cell Line | 4 | 2012 | 301 | 0.150 |
Why?
|
Models, Biological | 3 | 2007 | 343 | 0.140 |
Why?
|
Oxidation-Reduction | 1 | 2015 | 73 | 0.130 |
Why?
|
Cells, Cultured | 4 | 2013 | 688 | 0.130 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2015 | 32 | 0.130 |
Why?
|
Hematologic Neoplasms | 1 | 2014 | 17 | 0.130 |
Why?
|
Heart Ventricles | 2 | 2013 | 180 | 0.120 |
Why?
|
Liver Neoplasms | 1 | 2015 | 103 | 0.120 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2014 | 200 | 0.120 |
Why?
|
Metabolic Syndrome | 1 | 2014 | 65 | 0.120 |
Why?
|
Ventricular Dysfunction | 1 | 2013 | 2 | 0.120 |
Why?
|
United States | 2 | 2020 | 2331 | 0.120 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2013 | 14 | 0.120 |
Why?
|
Doxorubicin | 1 | 2013 | 45 | 0.120 |
Why?
|
Glucose | 1 | 2013 | 59 | 0.120 |
Why?
|
Leupeptins | 1 | 2012 | 4 | 0.110 |
Why?
|
Lovastatin | 1 | 2012 | 5 | 0.110 |
Why?
|
HEK293 Cells | 1 | 2012 | 73 | 0.110 |
Why?
|
In Vitro Techniques | 1 | 2012 | 214 | 0.110 |
Why?
|
Research Design | 1 | 2013 | 212 | 0.110 |
Why?
|
Myoblasts | 2 | 2008 | 2 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 145 | 0.100 |
Why?
|
Signal Transduction | 3 | 2014 | 486 | 0.100 |
Why?
|
Obesity | 1 | 2014 | 292 | 0.100 |
Why?
|
Gene Expression Regulation | 2 | 2009 | 288 | 0.090 |
Why?
|
Phospholipid Transfer Proteins | 1 | 2009 | 1 | 0.090 |
Why?
|
Thermogenesis | 1 | 2009 | 3 | 0.090 |
Why?
|
Fatty Liver | 1 | 2009 | 30 | 0.090 |
Why?
|
Models, Molecular | 2 | 2006 | 81 | 0.090 |
Why?
|
Chromans | 1 | 2008 | 2 | 0.090 |
Why?
|
Thiazolidinediones | 1 | 2008 | 14 | 0.090 |
Why?
|
Lipid Metabolism | 3 | 2014 | 31 | 0.080 |
Why?
|
Proteins | 2 | 2005 | 72 | 0.080 |
Why?
|
Insulin | 1 | 2008 | 92 | 0.080 |
Why?
|
RNA, Messenger | 1 | 2008 | 326 | 0.080 |
Why?
|
Immunohistochemistry | 1 | 2008 | 392 | 0.080 |
Why?
|
Biopsy, Fine-Needle | 1 | 2007 | 50 | 0.080 |
Why?
|
Pituitary Gland | 1 | 2007 | 8 | 0.080 |
Why?
|
Kaempferols | 1 | 2007 | 7 | 0.080 |
Why?
|
Binding Sites | 2 | 2005 | 73 | 0.080 |
Why?
|
Protein Conformation | 1 | 2006 | 69 | 0.070 |
Why?
|
Kinetics | 2 | 2004 | 226 | 0.070 |
Why?
|
Bile Acids and Salts | 1 | 2006 | 11 | 0.070 |
Why?
|
Recombinant Proteins | 2 | 2003 | 251 | 0.070 |
Why?
|
Parathyroid Hormone-Related Protein | 1 | 2005 | 5 | 0.070 |
Why?
|
Trans-Activators | 1 | 2005 | 24 | 0.070 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2005 | 36 | 0.070 |
Why?
|
Growth Plate | 1 | 2005 | 23 | 0.070 |
Why?
|
Adult | 3 | 2014 | 8594 | 0.070 |
Why?
|
Thyrotoxicosis | 1 | 2004 | 1 | 0.060 |
Why?
|
Up-Regulation | 1 | 2005 | 177 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2005 | 123 | 0.060 |
Why?
|
Female | 5 | 2014 | 16205 | 0.060 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2004 | 10 | 0.060 |
Why?
|
Cycloheximide | 1 | 2003 | 10 | 0.060 |
Why?
|
Cloning, Molecular | 1 | 2003 | 32 | 0.060 |
Why?
|
Male | 5 | 2013 | 15633 | 0.060 |
Why?
|
Dimerization | 1 | 2003 | 16 | 0.060 |
Why?
|
Myocardium | 1 | 2004 | 143 | 0.060 |
Why?
|
Neuropsychological Tests | 1 | 2007 | 1251 | 0.060 |
Why?
|
Cyclic AMP | 3 | 2007 | 23 | 0.050 |
Why?
|
Thyroid Diseases | 2 | 2013 | 14 | 0.050 |
Why?
|
Ultrasonography | 2 | 2013 | 226 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2013 | 254 | 0.040 |
Why?
|
Muscle, Skeletal | 3 | 2006 | 349 | 0.040 |
Why?
|
Brain | 1 | 2007 | 1689 | 0.040 |
Why?
|
Gene Expression Profiling | 2 | 2009 | 153 | 0.040 |
Why?
|
Norepinephrine | 2 | 2009 | 18 | 0.040 |
Why?
|
Transcription Factors | 2 | 2009 | 156 | 0.040 |
Why?
|
RNA Interference | 2 | 2007 | 33 | 0.040 |
Why?
|
Blotting, Western | 2 | 2009 | 170 | 0.040 |
Why?
|
Muscle Cells | 2 | 2006 | 14 | 0.030 |
Why?
|
Thyroid Function Tests | 1 | 2014 | 8 | 0.030 |
Why?
|
Transfection | 2 | 2005 | 125 | 0.030 |
Why?
|
Iodine | 1 | 2013 | 2 | 0.030 |
Why?
|
Glucose Clamp Technique | 1 | 2013 | 1 | 0.030 |
Why?
|
Glucose Transporter Type 1 | 1 | 2013 | 7 | 0.030 |
Why?
|
Models, Animal | 1 | 2013 | 126 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2013 | 15 | 0.030 |
Why?
|
Gene Expression | 2 | 2005 | 226 | 0.030 |
Why?
|
Behavior, Animal | 1 | 2013 | 107 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2013 | 56 | 0.030 |
Why?
|
Survival Analysis | 1 | 2013 | 298 | 0.030 |
Why?
|
Pregnancy | 1 | 2013 | 403 | 0.030 |
Why?
|
Mutation | 2 | 2005 | 383 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2013 | 788 | 0.020 |
Why?
|
Receptors, Leptin | 1 | 2009 | 1 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2009 | 6 | 0.020 |
Why?
|
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2009 | 7 | 0.020 |
Why?
|
Thiolester Hydrolases | 1 | 2009 | 1 | 0.020 |
Why?
|
Adipocytes | 1 | 2009 | 11 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2009 | 70 | 0.020 |
Why?
|
Body Temperature | 1 | 2009 | 58 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2009 | 85 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2009 | 55 | 0.020 |
Why?
|
Thyroidectomy | 1 | 2007 | 11 | 0.020 |
Why?
|
Cytodiagnosis | 1 | 2007 | 15 | 0.020 |
Why?
|
Cyclic AMP-Dependent Protein Kinase Type II | 1 | 2007 | 1 | 0.020 |
Why?
|
Chalcones | 1 | 2007 | 3 | 0.020 |
Why?
|
Stilbenes | 1 | 2007 | 4 | 0.020 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2007 | 30 | 0.020 |
Why?
|
Cholic Acid | 1 | 2006 | 1 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2007 | 521 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 552 | 0.020 |
Why?
|
Dietary Fats | 1 | 2006 | 22 | 0.020 |
Why?
|
Gene Deletion | 1 | 2006 | 41 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2007 | 438 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2006 | 26 | 0.020 |
Why?
|
Carbon Dioxide | 1 | 2006 | 20 | 0.020 |
Why?
|
Molecular Structure | 1 | 2005 | 29 | 0.020 |
Why?
|
Smad Proteins | 1 | 2005 | 6 | 0.020 |
Why?
|
Epithelium | 1 | 2005 | 26 | 0.020 |
Why?
|
Elongin | 1 | 2005 | 2 | 0.020 |
Why?
|
beta-Transducin Repeat-Containing Proteins | 1 | 2005 | 2 | 0.020 |
Why?
|
Two-Hybrid System Techniques | 1 | 2005 | 3 | 0.020 |
Why?
|
Chick Embryo | 1 | 2005 | 20 | 0.020 |
Why?
|
Hemangioma | 1 | 2005 | 8 | 0.020 |
Why?
|
Hedgehog Proteins | 1 | 2005 | 10 | 0.020 |
Why?
|
Protein Subunits | 1 | 2005 | 22 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2005 | 24 | 0.020 |
Why?
|
Adiposity | 1 | 2006 | 47 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2005 | 45 | 0.020 |
Why?
|
Ubiquitin | 1 | 2005 | 24 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2005 | 46 | 0.020 |
Why?
|
Body Weight | 1 | 2006 | 133 | 0.020 |
Why?
|
Estradiol | 1 | 2005 | 58 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2005 | 84 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2005 | 109 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2005 | 56 | 0.020 |
Why?
|
Protein Binding | 1 | 2005 | 128 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2005 | 193 | 0.020 |
Why?
|
Fibroblasts | 1 | 2005 | 97 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2005 | 246 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2005 | 147 | 0.020 |
Why?
|
Middle Aged | 2 | 2009 | 9818 | 0.020 |
Why?
|
Rats | 1 | 2007 | 857 | 0.020 |
Why?
|
Colforsin | 1 | 2004 | 10 | 0.020 |
Why?
|
Adenylyl Cyclases | 1 | 2004 | 10 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 2004 | 10 | 0.020 |
Why?
|
Isoenzymes | 1 | 2004 | 51 | 0.020 |
Why?
|
Cell Membrane | 1 | 2004 | 105 | 0.010 |
Why?
|
Chondrocytes | 1 | 2005 | 197 | 0.010 |
Why?
|
Heart | 1 | 2004 | 95 | 0.010 |
Why?
|
Selenium Radioisotopes | 1 | 2003 | 1 | 0.010 |
Why?
|
Dithiothreitol | 1 | 2003 | 4 | 0.010 |
Why?
|
Immunosorbent Techniques | 1 | 2003 | 4 | 0.010 |
Why?
|
Isotope Labeling | 1 | 2003 | 4 | 0.010 |
Why?
|
Catalysis | 1 | 2003 | 13 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2003 | 19 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 38 | 0.010 |
Why?
|
Molecular Weight | 1 | 2003 | 45 | 0.010 |
Why?
|
Disulfides | 1 | 2003 | 12 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2003 | 45 | 0.010 |
Why?
|
Tibia | 1 | 2005 | 259 | 0.010 |
Why?
|
Myocytes, Cardiac | 1 | 2004 | 198 | 0.010 |
Why?
|
Adolescent | 1 | 2007 | 2275 | 0.010 |
Why?
|
Aged | 1 | 2007 | 9441 | 0.010 |
Why?
|